A recent study by UBC’s Lucija Tomljenovic, PhD and Chris Shaw, PhD was published in Current Medical Chemistry and concludes that…
“The continued use of aluminum adjuvants in various vaccines for children as well as the general public may be of significant concern. In particular, aluminum presented in this form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may have profound and widespread adverse health consequences.”